17. NMA results for AEs (all risk groups combined).

Results of network meta‐analysis for outcome all‐cause AEs (grades 3 and 4). Treatments are ordered by P‐Score (descending). Only subnetworks with >1 designs. Upper triangle: direct estimate. Lower triangle: network estimate. Subnet 1 No. of studies: 10. No. of pairwise comparisons: 14. No. of treatments: 11. No. of designs: 10. Qtotal= 0.31, df = 2, P =0.85; Qwithin= 0.0, df = 0, P = n.a.; Qbetween=0.31, df = 2, P = 0.85; I² = 0.0%, Tau² = 0.0 Treatment Effects + 95%‐CIs (Risk ratios, random‐effects model):
ATE	0.63 [0.47, 0.83]	.	.	.	0.58 [0.44, 0.76]	.	.	.	.	.
0.64 [0.49, 0.83]	ATE+BEV	.	.	.	0.89 [0.81, 0.97]	.	.	.	.	.
0.70 [0.44, 1.11]	1.09 [0.74, 1.61]	NIN	.	.	0.82 [0.56, 1.20]	.	.	.	.	.
0.59 [0.44, 0.78]	0.92 [0.80, 1.06]	0.84 [0.57, 1.26]	SOR	.	0.99 [0.85, 1.14]	0.92 [0.78, 1.09]	.	.	.	.
0.57 [0.43, 0.75]	0.89 [0.79, 1.01]	0.82 [0.55, 1.21]	0.97 [0.84, 1.12]	AVE+AXI	1.00 [0.92, 1.08]	.	.	.	.	.
0.57 [0.44, 0.74]	0.89 [0.81, 0.97]	0.82 [0.56, 1.20]	0.97 [0.86, 1.08]	1.00 [0.92, 1.08]	SUN	0.98 [0.92, 1.05]	0.96 [0.77, 1.21]	0.94 [0.85, 1.03]	0.87 [0.80, 0.95]	0.86 [0.80, 0.94]
0.56 [0.43, 0.73]	0.87 [0.78, 0.97]	0.80 [0.54, 1.18]	0.95 [0.84, 1.06]	0.98 [0.88, 1.09]	0.98 [0.92, 1.05]	PAZ	.	.	.	.
0.55 [0.39, 0.77]	0.85 [0.67, 1.09]	0.78 [0.50, 1.22]	0.93 [0.72, 1.20]	0.96 [0.75, 1.22]	0.96 [0.77, 1.21]	0.98 [0.77, 1.24]	CAB	.	.	.
0.53 [0.40, 0.70]	0.83 [0.73, 0.95]	0.77 [0.52, 1.13]	0.91 [0.78, 1.05]	0.93 [0.82, 1.06]	0.94 [0.85, 1.03]	0.96 [0.85, 1.07]	0.98 [0.76, 1.25]	NIV+CAB	.	.
0.50 [0.38, 0.65]	0.77 [0.69, 0.87]	0.71 [0.48, 1.05]	0.84 [0.73, 0.97]	0.87 [0.77, 0.98]	0.87 [0.80, 0.95]	0.89 [0.80, 0.99]	0.91 [0.71, 1.15]	0.93 [0.82, 1.05]	LEN+PEM	0.99 [0.93, 1.06]
0.49 [0.37, 0.64]	0.77 [0.68, 0.87]	0.70 [0.48, 1.04]	0.83 [0.73, 0.96]	0.86 [0.76, 0.97]	0.86 [0.80, 0.94]	0.88 [0.79, 0.98]	0.90 [0.71, 1.14]	0.92 [0.81, 1.04]	0.99 [0.93, 1.06]	LEN+EVE